BioCentury | Nov 25, 2020
Product Development
Nov. 25 Quick Takes: FDA approves Y-mAbs’ Danyelza; plus NIH’s ACTT-4; COVAXX, Urovant, SomaLogic, Eluminex and Liquidia
...Stanford University and was CMO at Graybug Vision Inc. (NASDAQ:GRAY).Setback for Liquidia PAH therapyThe Liquidia Technologies Inc. subsidiary of Liquidia...
...GS-5734) Beova, vibegron (KRP-114V, MK-4618, RVT-901, SNV004) LIQ861 NIH Gilead Sciences Inc. Eli Lilly and Co. Incyte Corp. United Biomedical Inc. Urovant Sciences Ltd. Liquidia Technologies Inc. Gastrointestinal Ophthalmic Cardiovascular Irritable...
...GS-5734) Beova, vibegron (KRP-114V, MK-4618, RVT-901, SNV004) LIQ861 NIH Gilead Sciences Inc. Eli Lilly and Co. Incyte Corp. United Biomedical Inc. Urovant Sciences Ltd. Liquidia Technologies Inc. Gastrointestinal Ophthalmic Cardiovascular Irritable...